Naomi Patel, MD

Massachusetts General Hospital
Boston, MA, United States

Dr. Patel (previously Dr. Serling-Boyd) completed her undergraduate and medical education at the University of California, Los Angeles. She then completed her Internal Medicine residency and chief residency at Stanford and her rheumatology fellowship at Massachusetts General Hospital. Her research interests include vasculitis and quantifying and reducing glucocorticoid toxicity. Her current projects are focused on better quantifying glucocorticoid toxicity and its associations with quality of life and healthcare resource utilization in rheumatic diseases.

Disclosure information not submitted.

Presentation(s):

• 0460: Baseline Glucocorticoid Toxicity in the Treatment of Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0461: The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c During the Treatment of Giant Cell Arteritis

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0710: Risk Factors Associated with COVID-19 Breakthrough Infection Among Patients with Systemic Autoimmune Rheumatic Diseases: A Cohort Study

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 0794: Impact of Vaccination on Post-acute Sequelae of SARS CoV-2 Infection in Patients with Rheumatic Diseases

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 1076: ANCA-Associated Vasculitis Treated with Avacopan versus a Standard Prednisone Taper: Glucocorticoid Toxicity Index Scores by Domain

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time